Wei-Kuang Liu

Title: Wei-Kuang Liu: Innovator in Cell Screening Techniques

Introduction

Wei-Kuang Liu is an esteemed inventor located in Taipei, Taiwan. With a significant contribution to the field of biotechnology, he holds two patents that enhance methodologies for cell screening, focusing on high levels of target protein expression. His work has substantial implications for research and development in various biopharmaceutical applications.

Latest Patents

Wei-Kuang Liu’s latest patents include innovative strategies for screening cells. The first patent, titled “Inhibition-based high-throughput screen strategy for cell clones,” discloses a method that introduces a DNA construct into host cells. This construct encodes both a target protein and an inhibitor to an endogenous selectable marker, enabling the screening and isolation of cells with reduced selectable marker expression. The second patent, “Vector for inhibition-based high-throughput screen strategy,” outlines a similar approach, demonstrating the versatility and effectiveness of this screening technology.

Career Highlights

Wei-Kuang Liu is affiliated with Scinopharm Taiwan Ltd., a company dedicated to developing advanced pharmaceutical products. His role significantly influences the company's research output and positions it favorably within the industry. Muhammad Omar’s contributions reflect his deep understanding of cell biology and genetic engineering, making him a valuable asset to the organization.

Collaborations

In his professional journey, Wei-Kuang Liu collaborates closely with Min-Pey Ding, his coworker at Scinopharm Taiwan Ltd. This partnership fosters innovation and helps maximize the impact of their research endeavors. Their joint efforts demonstrate the importance of collaboration in advancing scientific discovery.

Conclusion

Wei-Kuang Liu stands at the forefront of biotechnology innovation, demonstrating significant achievements in cell screening technologies. His patents not only advance the scientific community's understanding of protein expression but also pave the way for potential breakthroughs in therapeutics. As he continues his work, the influence of his contributions will likely resonate throughout the industry, inspiring future innovations.